focus -WSS

focus

author：leisure time 2025-10-02 13:04:04 - browse：1

Milken June 23 — Tina Reed, Paul Kluetz, John Oyler, and Solange Peters speak at the Milken Institute Future of Health Summit. Screen capture

The Covid-19 pandemic’s rapid spread across the world demanded a quick, collaborative response. Now, experts are asking how they can take the lessons from combating Covid-19 and apply them to diseases like cancer.

“As we look at Covid and the lessons we’re learning in the last year-and-a-half, it certainly is a lesson of successes and failures,” said John Oyler, CEO of BeiGene, in an event at the Milken Institute Future of Health Summit this week. “I strongly believe in oncology that we can and will learn from this set of experiences.”

The oncology community has already had to learn some of those lessons on the fly, as Covid-19 restrictions forced more patient care and clinical trials to be conducted remotely. Many researchers didn’t have the background or technology needed to carry out virtual assessments.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Congressmen charge Covid hearing ‘could have been an email’

WSS

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Roche subsidiary Foundation Medicine opens new headquarters

Commercial surrogacy can be ethical, despite pope’s claims

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

The real point of Kenneth Smith’s execution by nitrogen gas

A $475,000 price tag for a new cancer drug: crazy or meh?

entertainment

focus

hotspot

How one medical school became remarkably diverse

Cognito secures funding to test medical device for Alzheimer's

United colonoscopy coverage change 'may cost lives,' doctors say

Do digital therapeutics have a future in medicine?

United colonoscopy coverage change 'may cost lives,' doctors say

Oprah kicked off a national conversation on obesity. Let's have it

Bright Health sells Medicare Advantage business to Molina

A $475,000 price tag for a new cancer drug: crazy or meh?

FDA approval of Sarepta Duchenne genetic therapy gives me hope

New Ultima Genomics DNA sequencer can read genome for $100

entertainment

Congressmen charge Covid hearing ‘could have been an email’

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Vertigo drug brings hope for rare neuron disorder, Niemann

ARCH Venture Partners is raising $3 billion for a life sciences fund

Abortion pill case raises question: who can sue the FDA?

focus

hotspot

Wikipedia

explore